Article information
Full text is only aviable in PDF
References
[1.]
C. Verdejo, G. Marín Hernández, B.P. Villacastín, G. Renedo, M.G. Largacha, M.L. Medina, et al.
Síndrome de las uñas amarillas: presentación de un caso y revisión de la literatura.
Rev Clin Esp, 191 (1992), pp. 152-155
[2.]
K.A. Christu, C. Pastaka, D. Papadopoulos, E. Klimi, K.I. Gourgoulianis.
Yellow nail syndrome or diffuse lymphatic disease.
Acta Medica (Hradec Králové), 45 (2002), pp. 181-182
[3.]
R.H. Bull, D.A. Fenton, P.S. Mortimer.
Lymphatic function in the yellow nail syndrome.
Br J Dermatol, 134 (1996), pp. 307-312
[4.]
N. Bilen, D. Bayramgürler, C. Devge, F. Bajdas, F. Yildiz, G. Töre.
Lymphoscintigraphy in yellow nail syndrome.
Int J Dermatol, 37 (1998), pp. 444-446
[5.]
A.S. Geyer, N. Onumah, Uyttendaele, R.K. Scher.
Modulation of linear nail growth to treat diseases of the nail.
J Am Acad Dermatol, 50 (2004), pp. 229-234
[6.]
G. Pitarch-Bort, E. Roche-Gamon.
Síndrome de las uñas amarillas.
Piel, 20 (2005), pp. 530-532
[7.]
M. Ginarte, B. Monteagudo, J. Toribio.
Yellow nail syndrome and lung lymphoma.
Clin Exp Dermatol, 29 (2004), pp. 432-433
[8.]
M. Iqbal, L.J. Rossoff, K.A. Marzouk, H.N. Steinberg.
Yellow nail syndrome resolution of yellow nails after successful treatment of breast cancer.
Chest, 117 (2000), pp. 1516-1518
[9.]
A. Tosti, B.M. Piraccini, M. Iorizzo.
Systemic itraconazole in the yellow nail syndrome.
Br J Dermatol, 146 (2002), pp. 1064-1067
[10.]
J.F. Arroyo, M.L. Cohen.
Improvement of yellow nail syndrome with oral zinc supplementation.
Clin Exp Dermatol, 18 (1993), pp. 62-64
[11.]
R. Baran.
The new oral antifungal drugs in the treatment of the yellow nail syndrome.
Br J Dermatol, 147 (2002), pp. 180-195
[12.]
C. Luyten, J. Andre, C. Walraevens, P. De Doncker.
Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E.
Dermatology, 192 (1996), pp. 406-408
Copyright © 2007. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
